Janeen Doyle

Janeen brings more than 24 years of broad and strategic experience spanning large pharmaceutical companies, mid-sized biotech, and high-growth venture-backed enterprises to her role as Chief Corporate and Business Development Officer at Janux. Prior to joining Janux, Janeen most recently served as a Senior Partner and Senior Vice President of Corporate Partnerships and Program Development at Flagship Pioneering, a life sciences focused venture capital firm. At Flagship, she was responsible for strategy and execution of collaborations between Flagship’s portfolio companies and global pharmaceutical and technology partners. Prior to Flagship, Janeen spent over 15 years at Bristol Myers Squibb and Celgene in a breadth of cross-functional positions of increasing responsibility, starting in areas of medical affairs and program leadership, and most recently serving as Senior Vice President of Strategy & Business Development. In that role, she oversaw a portfolio of 300+ strategic collaborations and a broad equity investing portfolio, including serving as a board observer across investments. Her leadership encompassed partnerships from discovery through commercialization across multiple therapeutic areas. Previous to that, she held roles in clinical science and operations.

Janeen received a Bachelor of Science in biology from Moravian University and a Master of Business Administration from the University of Scranton.